Raghavendra Pai's Biography

Raghavendra Pai, Chief-Quality Assurance & Compliance, Norwich Clinical Services - CRO, India

Dr. Raghavendra Pai is a distinguished professional in the field of clinical research, currently serving at Norwich Clinical. With a robust academic background and extensive experience, Dr. Pai has made significant contributions to the industry. Dr. Pai began his academic journey with a Bachelor’s degree in Pharmacy, where he developed a strong foundation in pharmaceutical sciences. He further advanced his knowledge by earning a Master’s degree in Clinical Research, equipping him with the skills necessary to navigate the complexities of clinical trials and drug development. His academic pursuits culminated in a Ph.D. in Pharmacology, where his research focused on the mechanisms of drug action and the development of new therapeutic strategies.With over two decades of experience in clinical research, Dr. Pai has held various pivotal roles.In addition to his professional accomplishments, Dr. Pai is an active member of various professional organizations. Dr. Raghavendra Pai's career reflects a commitment to advancing clinical research and improving patient outcomes. His blend of academic excellence and practical experience continues to drive innovation and set high standards in the field of clinical research.

other conference

Continuous Manufacturing in Biosimilars and Biologics
18 Jul, 2025

Continuous Manufacturing in Biosimilars and Biologics

Details
AI, and ML in Pharmaceutical R&D and Manufacturing Workflows
22 Aug, 2025

AI, and ML in Pharmaceutical R&D and Manufacturing Workflows

Details
Mastering Flow Chemistry: Scalable Solutions for API and Chemicals
17 Sep, 2025

Mastering Flow Chemistry: Scalable Solutions for API and Chemicals

Details
Flow Chemistry India 2025
18 - 19 Sep, 2025

Flow Chemistry India 2025

Ahmedabad

Details
Navigating Complexities in Pharmaceutical Analysis, Quality & Regulatory Compliance
06 - 07 Nov, 2025

Navigating Complexities in Pharmaceutical Analysis, Quality & Regulatory Compliance

Details
Advances in CRISPR-Cas Genome Editing in Plants
10 - 12 Dec, 2025

Advances in CRISPR-Cas Genome Editing in Plants

Details
whatsapp button